Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.

Next Previous
Trial Profile

Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Feb 2019

At a glance

  • Drugs TAC 302 (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Sponsors Taiho Pharmaceutical

    • Most Recent Events

    • 27 Jan 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
    • 27 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.
    • 07 Aug 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top